PETALING JAYA: The National Pharmaceutical Regulatory Agency (NPRA) requires 90 to 120 working days to review documents and make recommendations to the Drug Control Authority (DCA) on the registration of Covid-19 vaccines, says Health director-general Tan Sri Dr Noor Hisham Abdullah.
Dr Noor Hisham said all pharmaceutical products must be registered with the DCA following quality, safety and efficacy evaluations by NPRA before they can be marketed in Malaysia.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!